- Home
- PIII vs COCH Comparison
PIII vs COCH Comparison
Compare PIII & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIII
- COCH
- Stock Information
- Founded
- PIII 2015
- COCH 1995
- Country
- PIII United States
- COCH United States
- Employees
- PIII N/A
- COCH N/A
- Industry
- PIII Medical/Nursing Services
- COCH Blank Checks
- Sector
- PIII Health Care
- COCH Finance
- Exchange
- PIII Nasdaq
- COCH Nasdaq
- Market Cap
- PIII 21.4M
- COCH 31.6M
- IPO Year
- PIII N/A
- COCH N/A
- Fundamental
- Price
- PIII $6.23
- COCH $1.47
- Analyst Decision
- PIII Buy
- COCH Strong Buy
- Analyst Count
- PIII 2
- COCH 2
- Target Price
- PIII $16.25
- COCH $9.25
- AVG Volume (30 Days)
- PIII 3.7K
- COCH 25.8K
- Earning Date
- PIII 08-06-2025
- COCH 08-11-2025
- Dividend Yield
- PIII N/A
- COCH N/A
- EPS Growth
- PIII N/A
- COCH N/A
- EPS
- PIII N/A
- COCH N/A
- Revenue
- PIII $1,485,192,000.00
- COCH $212,000.00
- Revenue This Year
- PIII N/A
- COCH $8.04
- Revenue Next Year
- PIII $6.01
- COCH $15.39
- P/E Ratio
- PIII N/A
- COCH N/A
- Revenue Growth
- PIII 9.79
- COCH N/A
- 52 Week Low
- PIII $6.00
- COCH $1.21
- 52 Week High
- PIII $32.54
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- PIII 42.33
- COCH 48.45
- Support Level
- PIII $6.00
- COCH $1.40
- Resistance Level
- PIII $6.46
- COCH $1.58
- Average True Range (ATR)
- PIII 0.21
- COCH 0.10
- MACD
- PIII 0.07
- COCH 0.01
- Stochastic Oscillator
- PIII 33.33
- COCH 43.74
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.